Sage Journals: Discover world-class research

Retricted access

Research article

First published 2011-9

Low-dose naltrexone targets the opioid growth factor–opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model

Renee N Donahue, Patricia J McLaughlin, Ian S Zagon

Experimental Biology and Medicine

Retricted access

Research article

First published 2019-7

Naltrexone for the Treatment of Darier and Hailey-Hailey Diseases

Abdulhadi Jfri, Ivan V. Litvinov, Elena Netchiporouk

Journal of Cutaneous Medicine and Surgery

Retricted access

Research article

First published 2017-9

Featured Article: Serum [Met 5 ]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone

Michael D Ludwig, Ian S Zagon, Patricia J McLaughlin

Experimental Biology and Medicine

Retricted access

Research article

First published 2018-2

Featured Article: Modulation of the OGF–OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis

Michael D Ludwig, Ian S Zagon, Patricia J McLaughlin

Experimental Biology and Medicine

Retricted access

Other

First published 2009-11

Endogenous Opioids Regulate Expression of Experimental Autoimmune Encephalomyelitis: A New Paradigm for the Treatment of Multiple Sclerosis

Ian S. Zagon, Kristen A. Rahn, Anthony P. Turel [...]

Experimental Biology and Medicine

Retricted access

Research article

First published 2018-12

Intermittent blockade of OGFr and treatment of autoimmune disorders

Ian S Zagon, Patricia J McLaughlin

Experimental Biology and Medicine

Free access

Research article

First published 2009-12

Revisiting the ALA/N (α-Lipoic Acid/Low-Dose Naltrexone) Protocol for People With Metastatic and Nonmetastatic Pancreatic Cancer: A Report of 3 New Cases

Burton M. Berkson, Daniel M. Rubin, Arthur J. Berkson

Integrative Cancer Therapies

Retricted access

Research article

First published 2019-10

Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic,Nonmalignant Pain Syndromes

Diana Trofimovitch, Steven J. Baumrucker

American Journal of Hospice and Palliative Medicine®

Retricted access

Research article

First published 2008-9

A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis

M Gironi, F Martinelli-Boneschi, P Sacerdote [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2010-8

The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial

Naser Sharafaddinzadeh, Ali Moghtaderi, Davood Kashipazha [...]

Multiple Sclerosis Journal

Search results